April 2007
Paliperidone (Invega)
Paliperidone (Invega), recently approved to treat schizophrenia, is similar to risperidone (Risperidone) in efficacy and adverse effects.
Methylphenidate for ADHD in Preschool Children
Low doses of methylphenidate (Ritalin and others) are effective and safe for preschool children with ADHD but may cause more side effects than in older children.
A Case of Wernicke's Encephalopathy
Wernicke's encephalopathy is caused by thiamine deficiency, usually due to alcoholism or malnutrition.
In Brief
Taste Altered in Mood Disorders; Reduced Gray Matter May Predict Schizophrenia; FDA Issues Methadone Alert
Two Ineffective Adjuncts for Mania
Olanzapine (Zyprexa) and topiramate (Topamax) add no therapeutic benefit as adjunctive treatments for bipolar disorder.
Schizophrenia, Substance Abuse, and Violence
Substance abuse increases the risk of violent behavior in people with schizophrenia.
Paliperidone (Invega)
April 2007
February's "In Brief" mentioned the recent approval of the new antipsychotic paliperidone (Invega) by the US Food and Drug Administration (BTP 2007;30:7). An extended-release preparation, paliperidone is the principal active metabolite of risperidone (Risperdal). Kane and coauthors recently…
To view the rest of this article, please:
For current
BTP subscribers
Purchase access
to all articles
Purchase this article
for $3 (USD)